Advertisement

Topics

Coley Pharmaceutical Group Company Profile

13:07 EDT 24th September 2018 | BioPortfolio

Our proprietary TLR Therapeutics™ act by stimulating a specific class of targets, called Toll-like receptors, or TLRs, found in and on immune system cells which, in turn, direct the immune system to fight disease.
Coley’s pipeline of TLR Therapeutics includes four clinical-stage products targeting cancer, viral diseases, asthma and allergy:

Location

93 Worcester Street, Suite 101
Wellesley
Massachusetts
02481
United States of America

Contact

Phone: 1 781 431 9000
Fax: 1 781 431 6403
Email: corpcomm@coleypharma.com


News Articles [1002 Associated News Articles listed on BioPortfolio]

MD Anderson immunotherapy expert Sharma wins Coley Award

(University of Texas M. D. Anderson Cancer Center) Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson Cancer Center, has be...

EBOS Group achieves Australian pharmaceutical distribution deal

Australasia-based EBOS Group has won a tender to be the exclusive third-party distributor of pharmaceutical products to more than 400...Read More... The post EBOS Group achieves Australian pharmaceuti...

Oral formulation of AKYNZEO gains approval for use in Korea

Swiss pharmaceutical group, Helsinn, and professional pharmaceutical subsidiary of CJ Group, CJ Healthcare, have announced that the oral formulation of AKYNZEO has been approved for use in Korea by th...

Sudan:State Minister for Industry Welcomes Saudi Investment in Pharmaceutical Industry

The State Minister at Ministry of Industry , Dr. Abdou Dawod Suleiman dsicussed with delegation of Al-Faisalia Saudi Group headed by the Chair of the Group, Abdalla Al-Kenani, on Sunday increase of Sa...

Pharma experts stress that ‘doing nothing is not an option’, during recent seminar on Brexit impact

‘Doing nothing is not an option’ is the overriding message from pharmaceutical experts who attended the recent Pharmaceutical Industry Network Group (PING) seminar, held in conjunction with Ethica...

Teva Pharmaceutical Industries Ltd to Post Q1 2018 Earnings of $0.58...

Teva Pharmaceutical Industries Ltd - Jefferies Group issued their Q1 2018 earnings per share estimates for Teva Pharmaceutical Industries in a report released on Tuesday. Jefferies Group analyst D. St...

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China

Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Shandong (Luoxin) providing Luoxin exclusive rights to deve...

Medical imaging facility wins Pharmaceutical Innovation Network Group Innovation Award

A medical imaging facility located at Mount Vernon Hospital in Northwood, the Paul Strickland Scanner Centre, has won the 2018 Pharmaceutical Industry Network Group (PING) Innovation Award.

Drugs and Medications [335 Associated Drugs and Medications listed on BioPortfolio]

Emetrol cherry [WellSpring Pharmaceutical Corporation]

Emetrol

Cetirizine hydrochloride [Pharmaceutical Associates, Inc.]

Cetirizine Hydrochloride Syrup

Donepezil hydrochloride [Sun Pharmaceutical Industries Limited ]

These highlights do not include all the information needed to use donepezil hydrochloride safely and effectively. See full prescribing information for donepezil hydrochloride tablets Donepezil Hydroch...

Giltuss total release [Gil Pharmaceutical Corp]

Drug Facts

Dermasil [Rise International Group LLC]

PubMed Articles [2268 Associated PubMed Articles listed on BioPortfolio]

William Bradley Coley, MD, and the phenomenon of spontaneous regression.

The standard definition of spontaneous regression (SR) of cancer is as follows, "…when a malignant tumor partially or completely disappears without treatment or in the presence of therapy which is c...

The future of LC-MS for pharmaceutical analysis: an interview with Jun Qu.

Jun Qu speaks to Sankeetha Nadarajah, Editor of Bioanalysis: Jun Qu is the group leader of the proteomics and pharmaceutical analysis lab of SUNY-Buffalo (NY, USA) and a Professor in the Department of...

Multicenter retrospectie analysis on clinical characteristics and pharmaceutical therapy of elderly Patients with chronic heart failure.

To investigate the clinical characteristics and pharmaceutical therapy of elderly patients with chronic heart failure (CHF).Using the multi-center retrospective cross-sectional survey, we analyzed 1 7...

Icariside II Attenuates Chronic Hydrocephalus in an Experimental Subarachnoid Hemorrhage Rat Model.

Purpose To investigate the role of ICA II in subarachnoid hemorrhage (SAH)-  related chronic hydrocephalus. Methods A two hemorrhage injection model of SAH was created in Sprague Dawley rats (6-8 wee...

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...

Clinical Trials [4239 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

This protocol allows patients who completed Coley oncology studies using PF-3512676 (CPG 7909) Injection to continue receiving the treatment until disease progression.

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [2855 Associated Companies listed on BioPortfolio]

Coley Pharmaceutical Group

Our proprietary TLR Therapeutics™ act by stimulating a specific class of targets, called Toll-like receptors, or TLRs, found in and on immune system cells which, in turn, direct the immune system to...

URIACH

This has always been the halmark of Group Urlach throught its more than 160 years of existence,and has made it one of the leading pharmaceutical companies in Spanish and European markets.Pharmaceutica...

Goldshield Group plc

The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between...

China National Pharmaceutical Group Corporation(SINOPHARM)

China National Pharmaceutical Group Corporation (hereinafter referred to as SINOPHARM), founded on November 26, 1998, is China's largest pharmaceutical group company. Incorporating research with produ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Coley Pharmaceutical Group" on BioPortfolio

We have published hundreds of Coley Pharmaceutical Group news stories on BioPortfolio along with dozens of Coley Pharmaceutical Group Clinical Trials and PubMed Articles about Coley Pharmaceutical Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Coley Pharmaceutical Group Companies in our database. You can also find out about relevant Coley Pharmaceutical Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record